NIH-funded research R37 grant

Investigating how dendritic cells affect the immune response in cancer

Official title: Metabolic checkpoint in dendritic cell subsets and adaptive immunity

Funded at St. Jude Children's Research Hospital · NIH-11016907 · Data updated 2026-11-12

This study is looking at how certain immune cells help the body fight cancer, with the hope of finding new ways to boost the immune response for patients battling the disease.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startFebruary 1, 2024
Project endDecember 31, 2028
Funding year2025
Award (this year)$455,000
NIH project number5R37AI105887-12
Project IDNIH-11016907 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are cancer patients who are seeking innovative therapies to boost their immune response.

Less likely to help

Patients with non-cancerous conditions or those who are not currently undergoing cancer treatment may not receive any benefit from this research.

What this research studies

This research focuses on understanding the role of dendritic cell subsets in regulating the adaptive immune response, particularly in the context of cancer. By examining how these immune cells interact with cancer cells and influence anti-tumor immunity, the study aims to identify potential metabolic checkpoints that could be targeted for therapeutic benefit. Patients may benefit from insights gained into how their immune systems can be harnessed to fight cancer more effectively. The research employs advanced biochemical assays and algorithms to analyze immune responses and cancer progression.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing the body's immune response against cancer.

How similar studies have gone: Previous research has shown promising results in enhancing anti-tumor immunity through similar approaches, indicating a potential for success in this area.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Chi, Hongbo — St. Jude Children's Research Hospital
  • Study coordinator: Chi, Hongbo

Related research

Other NIH-funded projects on the same topics.

  • Investigating frailty and aging in childhood cancer survivors

    This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9890475

  • Investigating a specific type of leukemia in children caused by genetic changes.

    This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9834651

  • Accessible, label-free optical imaging to reveal disease signals

    A brain-friendly, patient-centered imaging approach aims to uncover hidden disease signals in cells and tissues without labels or dyes.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11627327

  • Targeting the SCP4 pathway in acute myeloid leukemia (AML)

    Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11617813

  • Blocking cancer-causing cMYC tricks after pregnancy changes in the breast

    Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11615605

  • Targeting aberrant enhancer landscapes in pancreatic cancer

    A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11611138

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.